Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May 20;18(5):1103.
doi: 10.3390/ijms18051103.

Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients

Volker Schirrmacher
Review

Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients

Volker Schirrmacher. Int J Mol Sci. .

Abstract

Newcastle disease (ND) is one of the most important diseases of poultry worldwide. In the last decades, molecular research has gained a lot of new information about its causative agent, newcastledisease virus (NDV). In poultry industry, certain strains of NDV have been used for preventive vaccination for more than 60 years. NDV has also been applied to cancer patients with beneficial effects for about 50 years, but this is less well known. The molecular basis for these differential effects of NDV in birds and man have been elucidated in the last decades and are explained in this review. The anti-neoplastic and immune-stimulatory properties in non-permissive hosts such as mouse and man have to do with the strong type I interferon responses induced in these foreign species. Additionally, NDV has the potential to break various types of tumor resistances and also to affect liver fibrosis. A main section is devoted to the benefits of clinical application of NDV and NDV-based vaccines to cancer patients. Reverse genetics technology allowed developing NDV into a vector suitable for gene therapy. Examples will be provided in which genetically engineered NDV is being used successfully as vector against new emerging viruses.

Keywords: EBOV; HN; ICD; NDV; RIG-I; V protein; cancer vaccine; dsRNA; immune escape; interferon.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Haasnoot J., Westerhout E.M., Berkhout B. RNA interference against viruses: Strike and counterstrike. Nat. Biotechnol. 2007;25:1435–1443. doi: 10.1038/nbt1369. - DOI - PMC - PubMed
    1. Moelling K., Broecke F. The reverse transcriptase-RNase H: From viruses to antiviral defense. Ann. N. Y. Acad. Sci. 2015;1341:126–135. doi: 10.1111/nyas.12668. - DOI - PubMed
    1. Moelling K. What contemporary viruses tell us about evolution: A personal view. Arch. Virol. 2013;158:1833–1848. doi: 10.1007/s00705-013-1679-6. - DOI - PMC - PubMed
    1. Schirrmacher V. Fifty years of clinical application of Newcastle Disease Virus: Time to celebrate! Biomedicines. 2016;4:16. doi: 10.3390/biomedicines4030016. - DOI - PMC - PubMed
    1. Hornung V., Ellegast J., Kim S., Brzózka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science. 2006;314:994–997. doi: 10.1126/science.1132505. - DOI - PubMed

MeSH terms

LinkOut - more resources